Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12074
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanagiotopoulos, Siannaen
dc.contributor.authorNayler, W Gen
dc.date.accessioned2015-05-16T01:43:13Z-
dc.date.available2015-05-16T01:43:13Z-
dc.date.issued1987-12-01en
dc.identifier.citationJournal of Cardiovascular Pharmacology; 10(6): 683-91en
dc.identifier.govdoc2450239en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12074en
dc.description.abstractThe excessive gain in Ca2+ that occurs when hearts are reperfused after prolonged periods of ischemia contributes to cell death and tissue necrosis. The following experiments were undertaken to determine whether nicotine, in a concentration equivalent to the peak concentration present in plasma after cigarette smoke inhalation, alters reperfusion-induced Ca2+ gain in isolated rat hearts. Nicotine (0.15 microgram/ml) failed to increase tissue Ca2+ during aerobic perfusion but increased Ca2+ gain during reperfusion after 30 (p less than 0.02) or 60 (p less than 0.02) min of normothermic ischemia. The increase of Ca2+ gain was independent of a nicotine-induced release of norepinephrine (NE) or an altered "reflow area", heart rate, force of contraction, or end-diastolic resting tension. Pretreatment for 3 days with anipamil (20 mg/kg), a long-acting calcium channel blocker, attenuated the reperfusion-induced Ca2+ gain after 30 min of global ischemia, and reduced (p less than 0.001) the nicotine-induced exacerbation of that gain, without altering tissue ATP or creatine phosphate (CP). Verapamil (1 X 10(-6) M) reduced (p less than 0.02) the nicotine-induced exacerbation of Ca2+ gain caused by reperfusion after 30 min of ischemia.en
dc.language.isoenen
dc.subject.otherAdenosine Triphosphate.analysisen
dc.subject.otherAnimalsen
dc.subject.otherCalcium.metabolismen
dc.subject.otherCalcium Channel Blockers.pharmacologyen
dc.subject.otherCoronary Circulation.drug effectsen
dc.subject.otherCoronary Disease.metabolism.physiopathologyen
dc.subject.otherFemaleen
dc.subject.otherHeart Rate.drug effectsen
dc.subject.otherIn Vitro Techniquesen
dc.subject.otherNicotine.toxicityen
dc.subject.otherNorepinephrine.metabolismen
dc.subject.otherPerfusionen
dc.subject.otherPhosphocreatine.analysisen
dc.subject.otherPropylamines.pharmacologyen
dc.subject.otherRatsen
dc.subject.otherRats, Inbred Strainsen
dc.titleNicotine-induced calcium overload during postischemic reperfusion.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Cardiovascular Pharmacologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pages683-91en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/2450239en
dc.identifier.orcid0000-0002-0845-0001-
dc.type.austinJournal Articleen
local.name.researcherPanagiotopoulos, Sianna
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptOffice for Research-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Dec 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.